US Patent 7820702 Sulfonylpyrrolidine modulators of androgen receptor function and method

Patent 7820702 was granted and assigned to Bristol-Myers Squibb on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7820702

Date of Patent

October 26, 2010

Patent Application Number

11048439

Date Filed

February 1, 2005

Patent Citations Received

‌

US Patent 11708318 Polymorphic forms of RAD1901-2HCL

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

Compounds are provided which are useful in the treatment of androgen receptor-associated conditions, such as age-related diseases, which compounds have the structure

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7820702 Sulfonylpyrrolidine modulators of androgen receptor function and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API